Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2007

01-09-2007 | Case Reports/Clinical Vignettes

Neurosarcoidosis Presenting as a Cerebellar Mass

Authors: Gautam Kumar, MBBS, MRCP(UK), Caroline A. Kang, MD, Caterina Giannini, MD

Published in: Journal of General Internal Medicine | Issue 9/2007

Login to get access

Abstract

CASE REPORT

A 74-year-old farmer presented with worsening headaches, gait unsteadiness, and writing difficulties. On examination, he had a tendency to fall to the right and right-sided dysmetria and dysdiadochokinesis. Magnetic resonance imaging initially showed abnormalities in the right cerebellar hemisphere, suggestive of subacute infarct or infiltrating malignancy. Suboccipital craniotomy and biopsy revealed noncaseating granulomas suggestive of sarcoidosis. He was initially treated with steroids and later switched to Infliximab. On follow-up 5 months later, symptoms and imaging had improved.

DISCUSSION

Sarcoidosis affects the central nervous system in about 5% of patients. It usually manifests with cranial nerve palsies. It may rarely mimic a tumor as in this patient. Despite the dearth of controlled studies addressing neurosarcoidosis treatment, excellent responses to corticosteroids have been documented. Infliximab has been used as a steroid-sparing agent in neurosarcoidosis. We present this case of neurosarcoidosis presenting as a cerebellar mass to increase awareness of this condition.
Literature
1.
go back to reference Boeck C. Multiple benign sarcoid of the skin. J Cutan Genito-Urin Dis. 1899;17:543–50. Boeck C. Multiple benign sarcoid of the skin. J Cutan Genito-Urin Dis. 1899;17:543–50.
2.
go back to reference Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909–17.PubMed Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909–17.PubMed
3.
go back to reference Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336–45.PubMed Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336–45.PubMed
4.
go back to reference Kidd D, Beynon HL. The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:85–94.PubMed Kidd D, Beynon HL. The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:85–94.PubMed
5.
go back to reference Mirfakhraee M, Crofford MJ, Guinto FC, Nauta HJ, Weedn VW. Virchow–Robin space: a path of spread in neurosarcoidosis. Radiology. 1986;158:715–20.PubMed Mirfakhraee M, Crofford MJ, Guinto FC, Nauta HJ, Weedn VW. Virchow–Robin space: a path of spread in neurosarcoidosis. Radiology. 1986;158:715–20.PubMed
6.
go back to reference Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med. 2002;8(5):457–63.PubMedCrossRef Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med. 2002;8(5):457–63.PubMedCrossRef
7.
go back to reference Wiesli P, Hess K, Cathomas G, Stey C. Neurosarcoidosis presenting as cerebellar mass. Eur Neurol. 2000;43(1):58–9.PubMedCrossRef Wiesli P, Hess K, Cathomas G, Stey C. Neurosarcoidosis presenting as cerebellar mass. Eur Neurol. 2000;43(1):58–9.PubMedCrossRef
8.
go back to reference Oksanen V. Neurosarcoidosis: clinical presentation and course in 50 patients. Acta Neurol Scand. 1986;73:283–90.PubMedCrossRef Oksanen V. Neurosarcoidosis: clinical presentation and course in 50 patients. Acta Neurol Scand. 1986;73:283–90.PubMedCrossRef
9.
go back to reference Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999;54:742–6.PubMedCrossRef Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999;54:742–6.PubMedCrossRef
10.
go back to reference Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol. 1991;49:1065–72. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol. 1991;49:1065–72.
11.
go back to reference Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest. 2003;124:2023–6.PubMedCrossRef Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest. 2003;124:2023–6.PubMedCrossRef
12.
go back to reference Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol. 1998;55:1248–54.PubMedCrossRef Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol. 1998;55:1248–54.PubMedCrossRef
13.
14.
go back to reference Sollberger M, Fluri F, Baumann T, et al. Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol. 2004;251(6):760–1.PubMedCrossRef Sollberger M, Fluri F, Baumann T, et al. Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol. 2004;251(6):760–1.PubMedCrossRef
15.
go back to reference Carter JD, Valeriano J, Vasey FB, Bognar B. Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med. 2004;117(4):277–9.PubMedCrossRef Carter JD, Valeriano J, Vasey FB, Bognar B. Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med. 2004;117(4):277–9.PubMedCrossRef
16.
go back to reference Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127(3):1064–71.PubMedCrossRef Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127(3):1064–71.PubMedCrossRef
17.
go back to reference Browne SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–8.CrossRef Browne SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–8.CrossRef
18.
go back to reference Foley KT, Howell JD, Junck L. Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis. Postgrad Med J. 1989;65:481–4.PubMedCrossRef Foley KT, Howell JD, Junck L. Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis. Postgrad Med J. 1989;65:481–4.PubMedCrossRef
19.
Metadata
Title
Neurosarcoidosis Presenting as a Cerebellar Mass
Authors
Gautam Kumar, MBBS, MRCP(UK)
Caroline A. Kang, MD
Caterina Giannini, MD
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0272-7

Other articles of this Issue 9/2007

Journal of General Internal Medicine 9/2007 Go to the issue

Letter to the Editor

Author Reply